Search for: "Pharmaceutical Research and Manufacturers of America"
Results 341 - 360
of 410
Sort by Relevance
|
Sort by Date
26 Jan 2009, 2:36 am
Meanwhile, the Pharmaceutical Research and Manufacturers of America (PhRMA) asserts that the issue is a need for more resources for the FDA, to keep drugs safe. [read post]
25 Jan 2009, 2:36 pm
The back-to-back purchases left Pfizer with a bloated research operation, excess manufacturing capacity and too few products in development to replace those going off patent, investors and analysts have said. [read post]
1 Jan 2009, 9:17 am
The code, drawn up by Pharmaceutical Research and Manufacturers of America, an industry group in Washington, bars drug companies from giving doctors branded pens, staplers, flash drives, paperweights, calculators and the like. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
18 Dec 2008, 4:10 pm
On Dec. 10, 2008, the Pharmaceutical Research and Manufacturers of America (“PhRMA”) released revised guidelines on direct-to-consumer (“DTC”) advertising that offer further direction to pharmaceutical research and biotechnology companies on providing accurate, accessible and useful information to consumers. [read post]
15 Dec 2008, 10:37 am
And despite the potential issues, the Pharmaceutical Research and Manufacturers of America supported the FDA initiative, because it will allow regulators and health care professionals to move from reliance on voluntary reporting of side effects to a more proactive monitoring of medicines. [read post]
8 Dec 2008, 3:11 pm
Opinion below (4th Circuit) Petition for certiorari Brief in opposition Petitioner's reply Brief amicus curiae of National League of Cities (in support of petitioner) Brief amici curiae of Pharmaceutical Research and Manufacturers of America, et al. [read post]
26 Nov 2008, 7:17 pm
Opinion below (4th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply Brief amicus curiae of National League of Cities (in support of petitioner) Brief amici curiae of Pharmaceutical Research and Manufacturers of America, et al. [read post]
25 Nov 2008, 6:00 pm
Basically, it’s because the FDA can’t rely only on the research handed in voluntarily by the pharmaceutical companies - because companies like Merck were ghost writing and heavily sponsoring the research so that the “research” made their products look good to the FDA in the drug approval process. [read post]
31 Oct 2008, 3:34 pm
” Moving on several years to March 2007, the FDA notified Takeda Pharmaceuticals of North America, Inc. that its diabetes drug, Actos was responsible for increased incidents of bone fractures in women using the drug. [read post]
23 Oct 2008, 10:31 am
WebMD (10/21, Hitti) provided reaction from Alan Goldhammer, Ph.D., vice president for scientific and regulatory affairs for the Pharmaceutical Research and Manufacturers of America (PhRMA), in response to both the study and the editorial. [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium,… [read post]
15 Oct 2008, 8:38 am
AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Novartis, Merck, and 3M.Less than six… [read post]
10 Oct 2008, 3:22 pm
This rapid product cycling demanded an annual research and development budget averaging 160 million dollars to gain an edge on the competition. [read post]
9 Oct 2008, 1:05 pm
The pharmaceutical industry, and its giant lobbying group, has tried to prohibit lawsuits against drug manufacturers because the drugs that are approved meet the seal of approval by the FDA. [read post]
9 Oct 2008, 1:05 pm
The pharmaceutical industry, and its giant lobbying group, has tried to prohibit lawsuits against drug manufacturers because the drugs that are approved meet the seal of approval by the FDA. [read post]
2 Oct 2008, 4:27 am
UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS UNITED STATES OF AMERICA ex rel. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
18 Sep 2008, 8:03 pm
On a marginal case, it helps to be a NAM member.PhRMA (Pharmaceutical Research & Manufacturers of America): PhRMA is the major trade association for producers of non-generic prescription drugs, so the primary focus of its amicus activity concerns cases involving product liability, antitrust, and patent issues that are of unique concern to the research-based pharmaceutical industry. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
